Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
NuGEN Technologies received early financing of $2.0M on 2000-11-01.
| Series | Round size | Date |
|---|---|---|
| Series A | $2M | 11/2000 |
| Series B | $10.8M | 12/2001 |
| Series C | $7.5M | 08/2003 |
| Debt Financing | $3M | 04/2007 |
| Series Unknown | $1.5M | 03/2010 |
| Series Unknown | $3.5M | 08/2011 |
| Debt Financing | $6.2M | 09/2014 |
| Investors | Security type |
|---|---|
| Tenex Medical Investors | Series A |
| MedCapital | Series B |
| Tenex Medical Investors | Series B |
| Pequot Capital | Series B |
| Band of Angels | Series B |
| Radius Ventures | Series B |
| Sutter Hill Ventures | Series C |
| MedCapital | Series C |
| Jim Wilson | Series C |
| Willam Rutter | Series C |
| George Rathmann | Series C |
| Band of Angels | Series C |
| Radius Ventures | Series C |
| HERCULES CAPITAL INC | Debt Financing |
NuGEN Technologies's top competitor, Aduro BioTech, earned an annual revenue of $17.3M.
NuGEN Technologies's smallest competitor is Zosano Pharma with revenue of $1.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| HTG Molecular Diagnostics | - | $6.4M | 107 | - |
| Aduro BioTech | - | $17.3M | 175 | - |
| Zosano Pharma | - | $1.0M | 53 | - |
| VGXI | - | $8.0M | 125 | - |
| Calypte Biomedical Corp. | - | $5.4M | 50 | - |
| Renmatix | - | $15.0M | 48 | - |
Zippia gives an in-depth look into the details of NuGEN Technologies, including salaries, political affiliations, employee data, and more, in order to inform job seekers about NuGEN Technologies. The employee data is based on information from people who have self-reported their past or current employments at NuGEN Technologies. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by NuGEN Technologies. The data presented on this page does not represent the view of NuGEN Technologies and its employees or that of Zippia.
NuGEN Technologies may also be known as or be related to NUGEN TECHNOLOGIES INC, NuGEN Technologies and Nugen Technologies, Inc.